Abstract

BackgroundHepatocellular carcinoma (HCC) is a common digestive tumor with great heterogeneity and different overall survival (OS) time, causing stern problems for selecting optimal treatment. Here we aim to establish a nomogram to predict the OS in HCC patients.MethodsInternational Cancer Genome Consortium (ICGC) database was searched for the target information in our study. Lasso regression, univariate and multivariate cox analysis were applied during the analysis process. And a nomogram integrating model scoring and clinical characteristic was drawn.ResultsSix mRNAs were screened out by Lasso regression to make a model for predicting the OS of HCC patients. And this model was proved to be an independent prognostic model predicting OS in HCC patients. The area under the ROC curve (AUC) of this model was 0.803. TCGA database validated the significant value of this 6-mRNA model. Eventually a nomogram including 6-mRNA risk score, gender, age, tumor stage and prior malignancy was set up to predict the OS in HCC patients.ConclusionsWe established an independent prognostic model of predicting OS for 1–3 years in HCC patients, which is available to all populations. And we developed a nomogram on the basis of this model, which could be of great help to precisely individual treatment measures.

Highlights

  • Hepatocellular carcinoma (HCC) is a common digestive tumor with great heterogeneity and different overall survival (OS) time, causing stern problems for selecting optimal treatment

  • BIRC3 induces growth and metastasis both in vitro and vivo in HCC [8]; CTHRC1 is related to invasion and metastasis in liver cancer [9]; the expression level of OCIAD2 is related to growth and invasion in HCC [10]

  • We developed a 6-mRNA prognostic model based on the International Cancer Genome Consortium (ICGC) database, which was verified in the The Cancer Genome Atlas (TCGA) database

Read more

Summary

Introduction

Hepatocellular carcinoma (HCC) is a common digestive tumor with great heterogeneity and different overall survival (OS) time, causing stern problems for selecting optimal treatment. Hepatocellular carcinoma (HCC) accounts for 75–85% of liver cancer and is the main type for dead cases in liver cancer [1]. Many literatures indicated that considering the low expression level of single gene, a combination of multiple genes can better predict the OS of HCC patients [11, 12]. Such models cannot accurately predict the OS of HCC patients, which has an impact on

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call